<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37751942</PMID><DateCompleted><Year>2023</Year><Month>10</Month><Day>04</Day></DateCompleted><DateRevised><Year>2023</Year><Month>10</Month><Day>04</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2632-1009</ISSN><JournalIssue CitedMedium="Internet"><Volume>30</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Sep</Month></PubDate></JournalIssue><Title>BMJ health &amp; care informatics</Title><ISOAbbreviation>BMJ Health Care Inform</ISOAbbreviation></Journal><ArticleTitle>Web-based eHealth Clinical Decision Support System as a tool for the treat-to-target management of patients with systemic lupus erythematosus: <i>development and initial usability evaluation</i>.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">e100811</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1136/bmjhci-2023-100811</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Treat-to-target (T2T) is a therapeutic strategy currently being studied for its application in systemic lupus erythematosus (SLE). Patients and rheumatologists have little support in making the best treatment decision in the context of a T2T strategy, thus, the use of information technology for systematically processing data and supporting information and knowledge may improve routine decision-making practices, helping to deliver value-based care.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To design and develop an online Clinical Decision Support Systems (CDSS) tool "SLE-T2T", and test its usability for the implementation of a T2T strategy in the management of patients with SLE.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A prototype of a CDSS was conceived as a web-based application with the task of generating appropriate treatment advice based on entered patients' data. Once developed, a System Usability Score (SUS) questionnaire was implemented to test whether the eHealth tool was user-friendly, comprehensible, easy-to-deliver and workflow-oriented. Data from the participants' comments were synthesised, and the elements in need for improvement were identified.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The beta version web-based system was developed based on the interim usability and acceptance evaluation. 7 participants completed the SUS survey. The median SUS score of SLE-T2T was 79 (scale 0 to 100), categorising the application as 'good' and indicating the need for minor improvements to the design.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">SLE-T2T is the first eHealth tool to be designed for the management of SLE patients in a T2T context. The SUS score and unstructured feedback showed high acceptance of this digital instrument for its future use in a clinical trial.</AbstractText><CopyrightInformation>&#xa9; Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Parra Sanchez</LastName><ForeName>Agner Russo</ForeName><Initials>AR</Initials><Identifier Source="ORCID">0000-0002-9553-0447</Identifier><AffiliationInfo><Affiliation>Rheumatology and Clinical Immunology, Amsterdam UMC Locatie VUmc, Amsterdam, Netherlands a.r.parrasanchez@amsterdamumc.nl.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Grimberg</LastName><ForeName>Max G</ForeName><Initials>MG</Initials><AffiliationInfo><Affiliation>Medical Informatics, University of Amsterdam Faculty of Medicine, Amsterdam, Noord-Holland, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hanssen</LastName><ForeName>Myrthe</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Medical Informatics, University of Amsterdam Faculty of Medicine, Amsterdam, Noord-Holland, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aben</LastName><ForeName>Moon</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Medical Informatics, University of Amsterdam Faculty of Medicine, Amsterdam, Noord-Holland, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jairth</LastName><ForeName>Elianne</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Medical Informatics, University of Amsterdam Faculty of Medicine, Amsterdam, Noord-Holland, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dhoeme</LastName><ForeName>Prishent</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Medical Informatics, University of Amsterdam Faculty of Medicine, Amsterdam, Noord-Holland, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tsang-A-Sjoe</LastName><ForeName>Michel W P</ForeName><Initials>MWP</Initials><AffiliationInfo><Affiliation>Rheumatology and Clinical Immunology, Amsterdam UMC Locatie VUmc, Amsterdam, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Voskuyl</LastName><ForeName>Alexandre</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Rheumatology and Clinical Immunology, Amsterdam UMC Locatie VUmc, Amsterdam, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jansen</LastName><ForeName>Hendrik Jan</ForeName><Initials>HJ</Initials><AffiliationInfo><Affiliation>Medical Informatics, University of Amsterdam Faculty of Medicine, Amsterdam, Noord-Holland, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van Vollenhoven</LastName><ForeName>Ronald</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Rheumatology and Clinical Immunology, Amsterdam UMC Locatie VUmc, Amsterdam, Netherlands.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMJ Health Care Inform</MedlineTA><NlmUniqueID>101745500</NlmUniqueID><ISSNLinking>2632-1009</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020000" MajorTopicYN="Y">Decision Support Systems, Clinical</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D063731" MajorTopicYN="Y">Mobile Applications</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017216" MajorTopicYN="Y">Telemedicine</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020407" MajorTopicYN="N">Internet</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">decision support systems, clinical</Keyword><Keyword MajorTopicYN="N">disease management</Keyword><Keyword MajorTopicYN="N">medical informatics</Keyword><Keyword MajorTopicYN="N">outcome assessment, health care</Keyword></KeywordList><CoiStatement>Competing interests: RV declares that he has received research support (institutional grants) from BMS, GSK, Lilly and UCB and support for educational programs from Pfizer and Roche. RV declares that he has also received consulting fees from AbbVie, AstraZeneca, Biogen, Biotest, BMS, Galapagos, Gilead, Janssen, Pfizer, Sanofi, Servier, UCB and Vielabio and personal honoraria as a speaker from AbbVie, Galapagos, GSK, Janssen, Pfizer and UCB. AV declares that he has received research support (institutional grants) from GSK and UCB. AV declares that he has also received consulting fees from GSK, AstraZeneca, Roche and personal honoraria as a speaker from GSK.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>5</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>9</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>10</Month><Day>4</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>9</Month><Day>27</Day><Hour>0</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>9</Month><Day>26</Day><Hour>21</Hour><Minute>3</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37751942</ArticleId><ArticleId IdType="pmc">PMC10533702</ArticleId><ArticleId IdType="doi">10.1136/bmjhci-2023-100811</ArticleId><ArticleId IdType="pii">bmjhci-2023-100811</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>D&#xf6;rner T, Furie R. Novel paradigms in systemic lupus erythematosus. Lancet 2019;393:2344&#x2013;58. 10.1016/S0140-6736(19)30546-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(19)30546-X</ArticleId><ArticleId IdType="pubmed">31180031</ArticleId></ArticleIdList></Reference><Reference><Citation>Narv&#xe1;ez J. Systemic lupus erythematosus 2020. Med Clin (Barc) 2020;155:494&#x2013;501. 10.1016/j.medcli.2020.05.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.medcli.2020.05.009</ArticleId><ArticleId IdType="pubmed">32586673</ArticleId></ArticleIdList></Reference><Reference><Citation>Bruce IN, O&#x2019;Keeffe AG, Farewell V, et al. . Factors associated with damage accrual in patients with systemic lupus erythematosus: results from the systemic lupus international collaborating clinics (SLICC) inception cohort. Ann Rheum Dis 2015;74:1706&#x2013;13. 10.1136/annrheumdis-2013-205171</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2013-205171</ArticleId><ArticleId IdType="pmc">PMC4552899</ArticleId><ArticleId IdType="pubmed">24834926</ArticleId></ArticleIdList></Reference><Reference><Citation>Parra S&#xe1;nchez AR, Voskuyl AE, van Vollenhoven RF. Treat-to-target in systemic lupus erythematosus: advancing towards its implementation. Nat Rev Rheumatol 2022;18:146&#x2013;57. 10.1038/s41584-021-00739-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41584-021-00739-3</ArticleId><ArticleId IdType="pubmed">35039665</ArticleId></ArticleIdList></Reference><Reference><Citation>Tunnicliffe D, Singh-Grewal D, Craig J, et al. . 384&#x2005;Multi-specialists&#x2019; perspectives on clinical decision making in systemic lupus erythematosus: an interview study. LUPUS 2017 &amp; ACA 2017, (12th International Congress on SLE &amp;, 7th Asian Congress on Autoimmunity); March 2017:A174&#x2013;7 10.1136/lupus-2017-000215.384</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/lupus-2017-000215.384</ArticleId></ArticleIdList></Reference><Reference><Citation>Ugarte-Gil MF, Burgos PI, Alarc&#xf3;n GS. Treat to target in systemic lupus erythematosus: a commentary. Clin Rheumatol 2016;35:1903&#x2013;7. 10.1007/s10067-016-3346-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10067-016-3346-2</ArticleId><ArticleId IdType="pubmed">27406378</ArticleId></ArticleIdList></Reference><Reference><Citation>van Vollenhoven RF, Mosca M, Bertsias G, et al. . Treat-to-target in systemic lupus erythematosus: recommendations from an international task force. Ann Rheum Dis 2014;73:958&#x2013;67. 10.1136/annrheumdis-2013-205139</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2013-205139</ArticleId><ArticleId IdType="pubmed">24739325</ArticleId></ArticleIdList></Reference><Reference><Citation>Muhiyaddin R, Abd-Alrazaq AA, Househ M, et al. . The impact of clinical decision support systems (CDSS) on physicians: a scoping review. Stud Health Technol Inform 2020;272:470&#x2013;3. 10.3233/SHTI200597</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/SHTI200597</ArticleId><ArticleId IdType="pubmed">32604704</ArticleId></ArticleIdList></Reference><Reference><Citation>Sutton RT, Pincock D, Baumgart DC, et al. . An overview of clinical decision support systems: benefits, risks, and strategies for success. NPJ Digit Med 2020;3:17. 10.1038/s41746-020-0221-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41746-020-0221-y</ArticleId><ArticleId IdType="pmc">PMC7005290</ArticleId><ArticleId IdType="pubmed">32047862</ArticleId></ArticleIdList></Reference><Reference><Citation>Lugtenberg M, Zegers-van Schaick JM, Westert GP, et al. . Why don't physicians adhere to guideline recommendations in practice? An analysis of barriers among Dutch general practitioners. Implement Sci 2009;4:54. 10.1186/1748-5908-4-54</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1748-5908-4-54</ArticleId><ArticleId IdType="pmc">PMC2734568</ArticleId><ArticleId IdType="pubmed">19674440</ArticleId></ArticleIdList></Reference><Reference><Citation>Fanouriakis A, Kostopoulou M, Alunno A, et al. . Update of the EULAR recommendations for the management of systemic lupus erythematosus. Ann Rheum Dis 2019;78:736&#x2013;45. 10.1136/annrheumdis-2019-215089</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2019-215089</ArticleId><ArticleId IdType="pubmed">30926722</ArticleId></ArticleIdList></Reference><Reference><Citation>Wasylewicz ATM. Scheepers-Hoeks A: clinical decision support systems. In: Kubben P, Dumontier M, Dekker A, eds. Fundamentals of clinical data science. Cham, CH, 2019: 153&#x2013;69. 10.1007/978-3-319-99713-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-3-319-99713-1</ArticleId><ArticleId IdType="pubmed">31314237</ArticleId></ArticleIdList></Reference><Reference><Citation>Sommerville I. Software engineering. Pearson, 2016.</Citation></Reference><Reference><Citation>Svanaes D, Das A, Alsos OA. The contextual nature of usability and its relevance to medical Informatics. Stud Health Technol Inform 2008;136:541&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">18487787</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooke J. SUS: a quick and dirty usability scale. Redhatch Consulting Ltd, 1995: 189.</Citation></Reference><Reference><Citation>Lewis J. Usability testing. 2006: 1275&#x2013;316. 10.1002/0470048204</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/0470048204</ArticleId></ArticleIdList></Reference><Reference><Citation>van Waes L. Thinking aloud as a method for testing the usability of websites: the influence of task variation on the evaluation of hypertext. IEEE Trans Profess Commun 2000;43:279&#x2013;91. 10.1109/47.867944</Citation><ArticleIdList><ArticleId IdType="doi">10.1109/47.867944</ArticleId></ArticleIdList></Reference><Reference><Citation>Bangor A, Kortum PT, Miller JT. An empirical evaluation of the system usability scale. International Journal of Human-Computer Interaction 2008;24:574&#x2013;94. 10.1080/10447310802205776</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/10447310802205776</ArticleId></ArticleIdList></Reference><Reference><Citation>Schaaf J, Sedlmayr M, Sedlmayr B, et al. . Evaluation of a clinical decision support system for rare diseases: a qualitative study. BMC Med Inform Decis Mak 2021;21:65. 10.1186/s12911-021-01435-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12911-021-01435-8</ArticleId><ArticleId IdType="pmc">PMC7890997</ArticleId><ArticleId IdType="pubmed">33602191</ArticleId></ArticleIdList></Reference><Reference><Citation>Labinsky H, Ukalovic D, Hartmann F, et al. . An AI-powered clinical decision support system to predict flares in rheumatoid arthritis: a pilot study. Diagnostics (Basel) 2023;13:148. 10.3390/diagnostics13010148</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/diagnostics13010148</ArticleId><ArticleId IdType="pmc">PMC9818406</ArticleId><ArticleId IdType="pubmed">36611439</ArticleId></ArticleIdList></Reference><Reference><Citation>Dantas LO, Weber S, Osani MC, et al. . Mobile health technologies for the management of systemic lupus erythematosus: a systematic review. Lupus 2020;29:144&#x2013;56. 10.1177/0961203319897139</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203319897139</ArticleId><ArticleId IdType="pmc">PMC6992477</ArticleId><ArticleId IdType="pubmed">31924145</ArticleId></ArticleIdList></Reference><Reference><Citation>Rubin J, Chisnell D, Spool J. Handbook of usability testing: how to plan, design, and conduct effective test. Wiley, 2011.</Citation></Reference><Reference><Citation>Bergier H, Duron L, Sordet C, et al. . Digital health, big data and smart technologies for the care of patients with systemic autoimmune diseases: where do we stand? Autoimmun Rev 2021;20:102864. 10.1016/j.autrev.2021.102864</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2021.102864</ArticleId><ArticleId IdType="pubmed">34118454</ArticleId></ArticleIdList></Reference><Reference><Citation>van Vollenhoven R, Bertsias G, Doria A, et al. . 2021 DORIS definition of remission in SLE: final recommendations from an international task force. Ann Rheum Dis 2021;80:181. 10.1136/annrheumdis-2021-eular.1192</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2021-eular.1192</ArticleId><ArticleId IdType="pmc">PMC8614136</ArticleId><ArticleId IdType="pubmed">34819388</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>